This interactive educational activity will provide an update on the latest research on the benefits of the standard and investigational therapies for patients with MS. Additionally, current perspectives on cognitive impairment in patients with MS and strategies that may have a role in preservation of cognitive function or treatment of cognitive impairment will be addressed.
Upon completion of this activity, participants will be able to:
This activity has been designed to meet the educational needs of US neurologists, advance practice nurses, and other clinicians involved in managing patients with multiple sclerosis.
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
In accordance with ACCME requirements, the Semel Institute for Neuroscience and Human Behavior at UCLA and the Institute for Medical Education, have a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Rhonda R. Voskuhl, MD Professor, Department of Neurology Director, Multiple Sclerosis Program University of California Los Angeles School of Medicine Los Angeles, California
Rhonda R. Voskuhl, MD, has a financial interest/relationship or affiliation in the form of: Consultant for Pipex Pharmaceuticals, Inc. Grant/Research Support from National Institutes of Health/National Multiple Sclerosis Society to study estriol treatment in multiple sclerosis.
Ralph H. B. Benedict, PhD Professor, Neurology, Psychiatry and Psychology Jacobs Neurological Institute, SUNY Buffalo School of Medicine Buffalo, New York
Ralph H. B. Benedict, PhD, has a financial interest/relationship or affiliation in the form of: Consultant for Bayer Corporation; Biogen Idec Inc.; Merck & Co., Inc.; and Novartis Pharmaceuticals Corporation.Grant/Research Support from National Institutes of Health; National Multiple Sclerosis Society; and Shire.Speakers Bureau participant with Abbott Laboratories; Bayer Corporation; and Biogen Idec Inc.
Sheldon Jordan, MD Neurologist, Pain Medicine Neurological Associates Santa Monica, California
Sheldon Jordan, MD, currently has no financial interests/relationships or affiliations in relation to this activity.
Andrew Leuchter, MD David Geffen School of Medicine at UCLA Semel Institute for Neuroscience and Human Behavior at UCLA Los Angeles, California
Kadrin Wilfong, MD PVI, PeerView Institute for Medical Education, Inc.
Kadrin Wilfong, MD, currently has no financial interests/relationships or affiliations in relation to this activity.
This program was developed and reviewed by faculty members of the David Geffen School of Medicine at UCLA. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Institute for Medical Education and the Semel Institute for Neuroscience and Human Behavior at UCLA, in association with PVI, PeerView Institute for Medical Education. The Institute for Medical Education takes responsibility for the content, quality and scientific integrity of this CME activity. The Institute for Medical Education designates this educational activity for a maximum of 0.5 hour of AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
The Semel Institute at UCLA is an accredited provider for continuing education credits for nurses (provider number CEP381). This course meets the qualifications for 0.5 hour of credit as required by the Board of Registered Nursing.
Note: Not all state nursing boards will accept programs less than 1.0 hour in length for credit. Please click here to find out the status of your state.
This CME/CNE activity is sponsored by the Semel Institute for Neuroscience and Human Behavior at UCLA and the Institute for Medical Education, in association with PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
All contents copyright © 2000-, PeerView Press. All rights reserved.
